Clinical Trials Browser

Interventional × peginterferon alfa-2a × 90 days × Clear all

NCT07288112 2026-02-23

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

Phase 1/2 Recruiting

Melanoma

NCT05799612 2026-02-13

Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma

Phase 1 Withdrawn

Hemangiosarcoma